Related Experiment Video
Updated: Jun 20, 2026

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
An exceedingly rare case of de novo hepatic angiosarcoma in a transplanted liver
Howard Chow1, Samer Ghattas1, Joshua Liu1
1Royal Prince Alfred Hospital, Level 5, 50 Missendon Road, Camperdown, New South Wales 2050, Australia.
Abstract:
De novo primary hepatic angiosarcoma is an exceedingly rare malignancy in transplanted livers. Only 1 previous case has been reported in the literature. The diagnosis is usually challenging due to non-specific clinical presentation and overlapping imaging findings with other conditions. These rapidly progressing, multifocal lesions have previously been described to have varied growth patterns but are typically hypo-enhancing on gadoxetate disodium (Primovist) enhanced MRI. Surgical resection and adjuvant chemotherapy are potential options of treatment for hepatic angiosarcomas. Despite this, prognosis of patients at diagnosis is extremely poor. In this report we present imaging findings of a liver transplant recipient despite biopsy-confirmed hepatic angiosarcoma, and discuss the diagnostic complexities involved.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

